Cargando…
Does Ibrutinib impact outcomes of viral infection by SARS-CoV-2 in mantle cell lymphoma patients?
Autores principales: | Alsuliman, Tamim, Faict, Sylvia, Malard, Florent, Genthon, Alexis, Brissot, Eolia, Van de Wyngaert, Zoé, Ikhlef, Souhila, Banet, Anne, Lapusan, Simona, Sestili, Simona, Corre, Elise, M’hammedi-Bouzina, Fella, Schaeffer, Louis, Legrand, Ollivier, Dulery, Rémy, Mohty, Mohamad, Marjanovic, Zora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687383/ https://www.ncbi.nlm.nih.gov/pubmed/33460953 http://dx.doi.org/10.1016/j.retram.2020.103273 |
Ejemplares similares
-
COVID-19 outcomes in patients with hematologic disease
por: Malard, Florent, et al.
Publicado: (2020) -
COVID-19 in the context of autologous hematopoietic stem cell transplantation for a patient with autoimmune disease
por: Alsuliman, Tamim, et al.
Publicado: (2022) -
Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation
por: Duléry, Rémy, et al.
Publicado: (2021) -
Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases
por: Otiniano, Armelle, et al.
Publicado: (2022) -
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
por: Malard, Florent, et al.
Publicado: (2021)